An evaluation of the latest in vitro tools for drug metabolism studies

Bibliography

• Klaass C. Casarett and Doulls's toxicology: the basic science of poisons. In: Klaassen, CD, editors, 7th edition. McGraw-Hill, New York City, USA; 2008
   Google Scholar
• Gad SC. Preclinical development handbook: toxicology. John Wiley & Sons, Hoboken, New Jersey; 2008
   Google Scholar
• Pieper I, Wechler K, Katzberg M, et al. Biosimulation of drug metabolism—A yeast based model. Eur J Pharm Sci 2009;36:157-70
   PubMed Web of Science ®Google Scholar
• Astashkina A, Mann B, Grainger DW. A critical evaluation of in vitro cell culture models for high-throughput drug screening and toxicity. Pharmacol Ther 2012;134:82-106
   PubMed Web of Science ®Google Scholar
• Pelkonen O, Turpeinen M, Uusitalo J, et al. Prediction of drug metabolism and interactions on the basis of in vitro investigations. Basic Clin Pharmacol 2005;96:167-75
   Google Scholar
• Venkatakrishnan K, von Moltke LL, Obach RS, Greenblatt DJ. Drug metabolism and drug interactions: application and clinical value of in vitro models. Curr Drug Metab 2003;4:423-59
   PubMed Web of Science ®Google Scholar
• Wrighton SA, Ring BJ, Vandenbranden M. The use of in vitro metabolism techniques in the planning and interpretation of drug safety studies. Toxicol Pathol 1995;23:199-208
   PubMed Web of Science ®Google Scholar
• De Kanter R, Olinga P, De Jager MH, et al. Organ slices as an in vitro test system for drug metabolism in human liver, lung and kidney. Toxicol In Vitro 1999;13:737-44
   PubMed Web of Science ®Google Scholar
• Vickers AEM, Fisher RL. Organ slices for the evaluation of human drug toxicity. Chem Biol Interact 2004;150:87-96
   PubMed Web of Science ®Google Scholar
• de Graaf IAM, Koster HJ. Cryopreservation of precision-cut tissue slices for application in drug metabolism research. Toxicol In Vitro 2003;17:1-17
   PubMed Web of Science ®Google Scholar
• Ekins S, Ring BJ, Grace J, et al. Present and future in vitro approaches for drug metabolism. J Pharmacol Toxicol 2000;44:313-24
   PubMed Web of Science ®Google Scholar
• Hariparsad N, Sane RS, Strom SC, Desai PB. In vitro methods in human drug biotransformation research: implications for cancer chemotherapy. Toxicol in Vitro 2006;20:135-53
   PubMed Web of Science ®Google Scholar
• Langowski J, Long A. Computer systems for the prediction of xenobiotic metabolism. Adv Drug Deliv Rev 2002;54:407-15
   PubMed Web of Science ®Google Scholar
• Raunio H. In silico toxicology–non-testing methods. Front Pharmacol 2011;2:1-8
   PubMed Web of Science ®Google Scholar
• Kirchmair J, Williamson MJ, Tyzack JD, et al. Computational prediction of metabolism: sites, products, SAR, P450 enzyme dynamics, and mechanisms. J Chem Inf Model 2012;52:617-48
   PubMed Web of Science ®Google Scholar
• Clewell RA, Clewell Iii HJ. Development and specification of physiologically based pharmacokinetic models for use in risk assessment. Regul Toxicol Pharmacol 2008;50:129-43
   PubMed Web of Science ®Google Scholar
• Jones HM, Gardner B, Watson KJ. Modelling and PBPK simulation in drug discovery. AAPS J 2009;11:155-66
   PubMed Web of Science ®Google Scholar
• Rowland M, Peck C, Tucker G. Physiologically-based pharmacokinetics in drug development and regulatory science. Annu Rev Pharmacol 2011;51:45-73
   Google Scholar
• Chen Y, Jin JY, Mukadam S, et al. Application of IVIVE and PBPK modeling in prospective prediction of clinical pharmacokinetics: strategy and approach during the drug discovery phase with four case studies. Biopharm Drug Dispos 2012;33:85-98
   PubMed Web of Science ®Google Scholar
• Heikkinen AT, Baneyx G, Caruso A, Parrott N. Application of PBPK modeling to predict human intestinal metabolism of CYP3A substrates – An evaluation and case study using GastroPlus™. Eur J Pharm Sci 2012;47:375-86
   PubMed Web of Science ®Google Scholar
• Fan J, Chen S, Chow ECY, Pang KS. PBPK modeling of intestinal and liver enzymes and transporters in drug absorption and sequential metabolism. Curr Drug Metab 2010;11:743-61
   PubMed Web of Science ®Google Scholar
• Guillouzo A, Morel F, Fardel O, Meunier B. Use of human hepatocyte cultures for drug metabolism studies. Toxicology 1993;82:209-19
   PubMed Web of Science ®Google Scholar
• Cheng N, Wauthier E, Reid LM. Mature human hepatocytes from ex vivo differentiation of alginate-encapsulated hepatoblasts. Tissue Eng Part A 2008;14:1-7
   PubMed Web of Science ®Google Scholar
• Lu H-F, Chua K-N, Zhang P-C, et al. Three-dimensional co-culture of rat hepatocyte spheroids and NIH/3T3 fibroblasts enhances hepatocyte functional maintenance. Acta Biomater 2005;1:399-410
   PubMed Web of Science ®Google Scholar
• Abu-Absi SF, Friend JR, Hansen LK, Hu W-S. Structural polarity and functional bile canaliculi in rat hepatocyte spheroids. Exp Cell Res 2002;274:56-67
   PubMed Web of Science ®Google Scholar
• Chiang T-S, Yang K-C, Zheng S-K, et al. The prediction of drug metabolism using scaffold-mediated enhancement of the induced cytochrome P450 activities in fibroblasts by hepatic transcriptional regulators. Biomaterials 2012;33:5187-97
   PubMed Web of Science ®Google Scholar
• Gaedtke L, Thoenes L, Culmsee C, et al. Proteomic analysis reveals differences in protein expression in spheroid versus monolayer cultures of low-passage colon carcinoma cells. J Proteome Res 2007;6:4111-18
   PubMed Web of Science ®Google Scholar
• Toh Y-C, Lim TC, Tai D, et al. A microfluidic 3D hepatocyte chip for drug toxicity testing. Lab Chip 2009;9:2026-35
   PubMed Web of Science ®Google Scholar
• Sivaraman A, Leach JK, Townsend S, et al. A microscale in vitro physiological model of the liver: predictive screens for drug metabolism and enzyme induction. Curr Drug Metab 2005;6:569-91
   PubMed Web of Science ®Google Scholar
• Leite SB, Teixeira AP, Miranda JP, et al. Merging bioreactor technology with 3D hepatocyte-fibroblast culturing approaches: improved in vitro models for toxicological applications. Toxicol In Vitro 2011;25:825-32
   PubMed Web of Science ®Google Scholar
• Kostadinova R, Boess F, Applegate D, et al. A long-term three dimensional liver co-culture system for improved prediction of clinically relevant drug-induced hepatotoxicity. Toxicol Appl Pharmacol 2013;268:1-16
   PubMed Web of Science ®Google Scholar
• Lin R-Z, Chang H-Y. Recent advances in three-dimensional multicellular spheroid culture for biomedical research. Biotechnol J 2008;3:1172-84
   PubMedGoogle Scholar
• Fennema E, Rivron N, Rouwkema J, et al. Spheroid culture as a tool for creating 3D complex tissues. Trends Biotechnol 2013;31:108-15
   PubMed Web of Science ®Google Scholar
• Miranda JP, Rodrigues A, Tostões RM, et al. Extending hepatocyte functionality for drug-testing applications using high-viscosity alginate–encapsulated three-dimensional cultures in bioreactors. Tissue Eng Part C 2010;16:1223-32
   PubMed Web of Science ®Google Scholar
• Lan S-F, Starly B. Alginate based 3D hydrogels as an in vitro co-culture model platform for the toxicity screening of new chemical entities. Toxicol Appl Pharmacol 2011;256:62-72
   PubMed Web of Science ®Google Scholar
• Chia SM, Leong KW, Li J, et al. Hepatocyte encapsulation for enhanced cellular functions. Tissue Eng 2000;6:481-95
   PubMedGoogle Scholar
• Schutte M, Fox B, Baradez MO, et al. Rat primary hepatocytes show enhanced performance and sensitivity to acetaminophen during three-dimensional culture on a polystyrene scaffold designed for routine use. Assay Drug Dev Technol 2011;9:475-86
   PubMed Web of Science ®Google Scholar
• Evenou F, Fujii T, Sakai Y. Liver cells culture on three-dimensional micropatterned polydimethylsiloxane surfaces. JSAAE 2007;14:665-8
   Google Scholar
• Kaufmann PM, Heimrath S, Kim BS, Mooney DJ. Highly porous polymer matrices as a three-dimensional culture system for hepatocytes. Cell Transplant 1997;6:463-8
   PubMed Web of Science ®Google Scholar
• Wang C, Varshney RR, Wang D-A. Therapeutic cell delivery and fate control in hydrogels and hydrogel hybrids. Adv Drug Deliv Rev 2010;62:699-710
   PubMed Web of Science ®Google Scholar
• Lee KY, Mooney DJ. Alginate: properties and biomedical applications. Prog Polym Sci 2012;37:106-26
   PubMed Web of Science ®Google Scholar
• Meli L, Jordan ET, Clark DS, et al. Influence of a three-dimensional, microarray environment on human Cell culture in drug screening systems. Biomaterials 2012;33:9087-96
   PubMed Web of Science ®Google Scholar
• Nakamura K, Mizutani R, Sanbe A, et al. Evaluation of drug toxicity with hepatocytes cultured in a micro-space cell culture system. J Biosci Bioeng 2011;111:78-84
   PubMed Web of Science ®Google Scholar
• Gurski LA, Jha AK, Zhang C, et al. Hyaluronic acid-based hydrogels as 3D matrices for in vitro evaluation of chemotherapeutic drugs using poorly adherent prostate cancer cells. Biomaterials 2009;30:6076-85
   PubMed Web of Science ®Google Scholar
• Horning JL, Sahoo SK, Vijayaraghavalu S, et al. 3-D tumor model for in vitro evaluation of anticancer drugs. Mol Pharm 2008;5:849-62
   PubMed Web of Science ®Google Scholar
• David L, Dulong V, Le Cerf D, et al. Hyaluronan hydrogel: an appropriate three-dimensional model for evaluation of anticancer drug sensitivity. Acta Biomater 2008;4:256-63
   PubMed Web of Science ®Google Scholar
• Lan S-F, Safiejko-Mroczka B, Starly B. Long-term cultivation of HepG2 liver cells encapsulated in alginate hydrogels: a study of cell viability, morphology and drug metabolism. Toxicol In Vitro 2010;24:1314-23
   PubMed Web of Science ®Google Scholar
• Naughton B, Sibanda B, Weintraub J, et al. A stereotypic, transplantable liver tissue-culture system. Appl Biochem Biotechnol 1995;54:65-91
   PubMed Web of Science ®Google Scholar
• Dash A, Inman W, Hoffmaster K, et al. Liver tissue engineering in the evaluation of drug safety. Expert Opin Drug Metab Toxicol 2009;5:1159-74
   PubMed Web of Science ®Google Scholar
• Khetani SR, Bhatia SN. Microscale culture of human liver cells for drug development. Nat Biotechnol 2008;26:120-6
   PubMed Web of Science ®Google Scholar
• Kuri-Harcuch W, Mendoza-Figueroa T. Cultivation of adult rat hepatocytes on 3T3 cells: expression of various liver differentiated functions. Differentiation 1989;41:148-57
   PubMed Web of Science ®Google Scholar
• Uyama N, Shimahara Y, Kawada N, et al. Regulation of cultured rat hepatocyte proliferation by stellate cells. J Hepatol 2002;36:590-9
   PubMed Web of Science ®Google Scholar
• Zinchenko YS, Culberson CR, Coger RN. Contribution of non-parenchymal cells to the performance of micropatterned hepatocytes. Tissue Eng 2006;12:2241-1251
   PubMedGoogle Scholar
• Bhandari R, Riccalton L, Lewis A, et al. Liver tissue engineering: a role for co-culture systems in modifying hepatocyte function and viability. Tissue Eng 2001;7:345-57
   PubMedGoogle Scholar
• Bhatia SN, Balis UJ, Yarmush ML, Toner M. Effect of cell–cell interactions in preservation of cellular phenotype: cocultivation of hepatocytes and nonparenchymal cells. FASEB J 1999;13:1883-900
   PubMed Web of Science ®Google Scholar
• Kidambi S, Sheng L, Yarmush ML, et al. Patterned co-culture of primary hepatocytes and fibroblasts using polyelectrolyte multilayer templates. Macromol Biosci 2007;7:344-53
   PubMed Web of Science ®Google Scholar
• Gerlach J. Use of hepatocyte cultures for liver support bioreactors. In: Felipo V, Grisolia S, editors. Hepatic encephalopathy, hyperammonemia, and ammonia toxicity. Springer; US: 1994. p. 165-71
   Google Scholar
• Varley J, Birch J. Reactor design for large scale suspension animal cell culture. Cytotechnology 1999;29:177-205
   PubMed Web of Science ®Google Scholar
• Tostões RM, Leite SB, Serra M, et al. Human liver cell spheroids in extended perfusion bioreactor culture for repeated-dose drug testing. Hepatology 2012;55:1227-36
   PubMed Web of Science ®Google Scholar
• Tostões RM, Leite SB, Miranda JP, et al. Perfusion of 3D encapsulated hepatocytes—A synergistic effect enhancing long-term functionality in bioreactors. Biotechnol Bioeng 2011;108:41-9
   PubMed Web of Science ®Google Scholar
• Guzzardi MA, Vozzi F, Ahluwalia AD. Study of the crosstalk between hepatocytes and endothelial cells using a novel multicompartmental bioreactor: a comparison between connected cultures and cocultures. Tissue Eng Part A 2009;15:3635-44
   PubMed Web of Science ®Google Scholar
• Mazzoleni G, Steimberg N. New models for the in vitro study of liver toxicity: 3D culture systems and the role of bioreactors. In: Tyshenko M, editor. The continuum of health risk assessments. InTech; Hampshire, UK: 2012. p. 161-94
   Google Scholar
• De Bruyn T, Chatterjee S, Fattah S, et al. Sandwich-cultured hepatocytes: utility for in vitro exploration of hepatobiliary drug disposition and drug-induced hepatotoxicity. Expert Opin Drug Metab Toxicol 2013;9:589-616
   PubMed Web of Science ®Google Scholar
• LeCluyse EL. Human hepatocyte culture systems for the in vitro evaluation of cytochrome P450 expression and regulation. Eur J Pharm Sci 2001;13:343-68
   PubMed Web of Science ®Google Scholar
• Ghibellini G, Vasist LS, Leslie EM, et al. In vitro-in vivo correlation of hepatobiliary drug clearance in humans. Clin Pharmacol Ther 2007;81:406-13
   PubMed Web of Science ®Google Scholar
• Boess F, Kamber M, Romer S, et al. Gene expression in two hepatic cell lines, cultured primary hepatocytes, and liver slices compared to the in vivo liver gene expression in rats: possible implications for toxicogenomics use of in vitro systems. Toxicol Sci 2003;73:386-402
   PubMed Web of Science ®Google Scholar
• Tuschl G, Hrach J, Walter Y, et al. Serum-free collagen sandwich cultures of adult rat hepatocytes maintain liver-like properties long term: a valuable model for in vitro toxicity and drug–drug interaction studies. Chem Biol Interact 2009;181:124-37
   PubMed Web of Science ®Google Scholar
• Tchaparian EH, Houghton JS, Uyeda C, et al. Effect of culture time on the basal expression levels of drug transporters in sandwich-cultured primary rat hepatocytes. Drug Metab Dispos 2011;39:2387-94
   PubMed Web of Science ®Google Scholar
• Soldatow VY, LeCluyse EL, Griffith LG, Rusyn I. In vitro models for liver toxicity testing. Toxicol Res 2013;2:23-9
   PubMed Web of Science ®Google Scholar
• Kimoto E, Walsky R, Zhang H, et al. Differential modulation of cytochrome P450 activity and the effect of 1-aminobenzotriazole on hepatic transport in sandwich-cultured human hepatocytes. Drug Metab Dispos 2012;40:407-11
   PubMed Web of Science ®Google Scholar
• Muller M, Jansen PL. Molecular aspects of hepatobiliary transport. Am J Physiol 1997;272:1285-303
   PubMed Web of Science ®Google Scholar
• Sai Y. Biochemical and molecular pharmacological aspects of transporters as determinants of drug disposition. Drug Metab Pharmacokinet 2005;20:91-9
   PubMedGoogle Scholar
• Morgan RE, Trauner M, van Staden CJ, et al. Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development. Toxicol Sci 2010;118:485-500
   PubMed Web of Science ®Google Scholar
• Borlak J, Klutcka T. Expression of basolateral and canalicular transporters in rat liver and cultures of primary hepatocytes. Xenobiotica 2004;34:935-47
   PubMed Web of Science ®Google Scholar
• Kotani N, Maeda K, Watanabe T, et al. Culture period-dependent changes in the uptake of transporter substrates in sandwich-cultured rat and human hepatocytes. Drug Metab Dispos 2011;39:1503-10
   PubMed Web of Science ®Google Scholar
• Jacobsen JK, Jensen B, Skonberg C, et al. Time-course activities of Oct1, Mrp3, and cytochrome P450s in cultures of cryopreserved rat hepatocytes. Eur J Pharm Sci 2011;44:427-36
   PubMed Web of Science ®Google Scholar
• Jørgensen L, Van Beek J, Lund S, et al. Evidence of Oatp and Mdr1 in cryopreserved rat hepatocytes. Eur J Pharm Sci 2007;30:181-9
   PubMed Web of Science ®Google Scholar
• Li N, Singh P, Mandrell KM, Lai Y. Improved extrapolation of hepatobiliary clearance from in vitro sandwich cultured rat hepatocytes through absolute quantification of hepatobiliary transporters. Mol Pharm 2010;7:630-41
   PubMed Web of Science ®Google Scholar
• Hoffmaster K, Turncliff R, LeCluyse E, et al. P-glycoprotein expression, localization, and function in sandwich-cultured primary rat and human hepatocytes: relevance to the hepatobiliary disposition of a model opioid peptide. Pharm Res 2004;21:1294-302
   PubMed Web of Science ®Google Scholar
• Takayama K, Inamura M, Kawabata K, et al. Generation of metabolically functioning hepatocytes from human pluripotent stem cells by FOXA2 and HNF1alpha transduction. J Hepatol 2012;57:628-36
   PubMed Web of Science ®Google Scholar
• Hay DC, Zhao D, Ross A, et al. Direct differentiation of human embryonic stem cells to hepatocyte-like cells exhibiting functional activities. Cloning Stem Cells 2007;9:51-62
   PubMedGoogle Scholar
• Hay DC, Zhao D, Fletcher J, et al. Efficient differentiation of hepatocytes from human embryonic stem cells exhibiting markers recapitulating liver development in vivo. Stem Cells 2008;26:894-902
   PubMed Web of Science ®Google Scholar
• Agarwal S, Holton KL, Lanza R. Efficient differentiation of functional hepatocytes from human embryonic stem cells. Stem Cells 2008;26:1117-27
   PubMed Web of Science ®Google Scholar
• Hay DC, Fletcher J, Payne C, et al. Highly efficient differentiation of hESCs to functional hepatic endoderm requires ActivinA and Wnt3a signaling. Proc Natl Acad Sci USA 2008;105:12301-6
   PubMed Web of Science ®Google Scholar
• Duan Y, Ma X, Zou W, et al. Differentiation and characterization of metabolically functioning hepatocytes from human embryonic stem cells. Stem Cells 2010;28:674-86
   PubMed Web of Science ®Google Scholar
• Song Z, Cai J, Liu Y, et al. Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells. Cell Res 2009;19:1233-42
   PubMed Web of Science ®Google Scholar
• Yi F, Liu G-H, Belmonte J. Human induced pluripotent stem cells derived hepatocytes: rising promise for disease modeling, drug development and cell therapy. Protein Cell 2012;3:246-50
   PubMedGoogle Scholar
• Alison MR, Poulsom R, Jeffery R, et al. Cell differentiation: Hepatocytes from non-hepatic adult stem cells. Nature 2000;406:257-7
   PubMed Web of Science ®Google Scholar
• Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature 2002;418:41-9
   PubMed Web of Science ®Google Scholar
• Scarpelli DG, Rao MS. Differentiation of regenerating pancreatic cells into hepatocyte-like cells. Proc Natl Acad Sci USA 1981;78:2577-81
   PubMed Web of Science ®Google Scholar
• Yu Y, Liu H, Ikeda Y, et al. Hepatocyte-like cells differentiated from human induced pluripotent stem cells: relevance to cellular therapies. Stem Cell Res 2012;9:196-207
   PubMed Web of Science ®Google Scholar
• Graaf IA, Groothuis GM, Olinga P. Precision-cut tissue slices as a tool to predict metabolism of novel drugs. Expert Opin Drug Metab Toxicol 2007;3:879-98
   PubMed Web of Science ®Google Scholar
• van Midwoud PM, Merema MT, Verpoorte E, Groothuis GMM. A microfluidic approach for in vitro assessment of interorgan interactions in drug metabolism using intestinal and liver slices. Lab Chip 2010;10:2778-86
   PubMed Web of Science ®Google Scholar
• Van Midwoud PM, Merema MT, Verweij N, et al. Hydrogel embedding of precision-cut liver slices in a microfluidic device improves drug metabolic activity. Biotechnol Bioeng 2011;108:1404-12
   PubMed Web of Science ®Google Scholar
• Khong Y, Zhang J, Zhou S, et al. Novel intra-tissue perfusion system for culturing thick liver tissue. Tissue Eng 2007;13:2345-56
   PubMedGoogle Scholar
• Schumacher K, Khong Y, Chang S, et al. Perfusion culture improves the maintenance of cultured liver tissue slices. Tissue Eng 2007;13:197-205
   PubMedGoogle Scholar
• van Midwoud PM, Merema MT, Verpoorte E, Groothuis GMM. Microfluidics enables small-scale tissue-based drug metabolism studies with scarce human tissue. J Assoc Lab Autom 2011;16:468-76
   Google Scholar
• Ganey PE, Luyendyk JP, Maddox JF, Roth RA. Adverse hepatic drug reactions: inflammatory episodes as consequence and contributor. Chem Biol Interact 2004;150:35-51
   PubMed Web of Science ®Google Scholar
• Adams DH, Ju C, Ramaiah SK, et al. Mechanisms of immune-mediated liver injury. Toxicol Sci 2010;115:307-21
   PubMed Web of Science ®Google Scholar
• Uetrecht J. Idiosyncratic drug reactions: past, present, and future. Chem Res Toxicol 2007;21:84-92
   PubMed Web of Science ®Google Scholar
• Shaw PJ, Ganey PE, Roth RA. Idiosyncratic drug-induced liver injury and the role of inflammatory stress with an emphasis on an animal model of trovafloxacin hepatotoxicity. Toxicol Sci 2010;118:7-18
   PubMed Web of Science ®Google Scholar
• Uetrecht J. Idiosyncratic drug reactions: current understanding. Annu Rev Pharmacol 2007;47:513-39
   Google Scholar
• Hadi M, Chen Y, Starokozhko V, et al. Mouse precision-cut liver slices as an ex vivo model to study idiosyncratic drug-induced liver injury. Chem Res Toxicol 2012;25:1938-47
   PubMed Web of Science ®Google Scholar
• Hadi M, Westra IM, Starokozhko V, et al. Human precision-cut liver slices as an ex vivo model to study idiosyncratic drug-induced liver injury. Chem Res Toxicol 2013;26:710-20
   PubMed Web of Science ®Google Scholar
• Obach R. Predicting clearance in humans from in vitro data. Curr Top Med Chem 2011;11:334-9
   PubMed Web of Science ®Google Scholar
• Riley RJ, McGinnity DF, Austin RP. A unified model for predicting human hepatic, metabolic clearance from in vitro intrinsic clearance data in hepatocytes and microssomes. Drug Metab Dispos 2005;33:1304-11
   PubMed Web of Science ®Google Scholar
• Blanchard N, Hewitt N, Silber P, et al. Prediction of hepatic clearance using cryopreserved human hepatocytes: a comparison of serum and serum-free incubations. J Pharm Pharmacol 2006;58:633-41
   PubMed Web of Science ®Google Scholar
• Poulin P, Hop CECA, Ho Q, et al. Comparative assessment of in vitro–in vivo extrapolation methods used for predicting hepatic metabolic clearance of drugs. J Pharm Sci 2012;101:4308-26
   PubMed Web of Science ®Google Scholar
• Chiba M, Ishii Y, Sugiyama Y. Prediction of hepatic clearance in human from in vitro data for successful drug development. AAPS J 2009;11:262-76
   PubMed Web of Science ®Google Scholar
• Houston J, Carlile D. Prediction of hepatic clearance from microsomes, hepatocytes, and liver slices. Drug Metab Rev 1997;29:891-22
   PubMed Web of Science ®Google Scholar
• Li AP. Human hepatocytes: isolation, cryopreservation and applications in drug development. Chem Biol Interact 2007;168:16-29
   PubMed Web of Science ®Google Scholar
• Hallifax D, Rawden HC, Hakooz N, Houston JB. Prediction of metabolic clearance using cryopreserved human hepatocytes: kinetics characteristics for five benzodiazepines. Drug Metab Dispos 2005;33:1852-8
   PubMed Web of Science ®Google Scholar
• Poulin P. Prediction of total hepatic clearance by combining metabolism, transport, and permeability data in the in vitro–in vivo extrapolation methods: emphasis on an apparent fraction unbound in liver for drugs. J Pharm Sci 2013;102:2085-95
   PubMed Web of Science ®Google Scholar
• Umehara KI, Camenisch G. Novel in vitro-in vivo extrapolation (IVIVE) method to predict hepatic organ clearance in rat. Pharm Res 2012;29:603-17
   PubMed Web of Science ®Google Scholar
• von Richter O, Burk O, Fromm MF, et al. Cytochrome P450 3A4 and P-glycoprotein expression in human small intestinal enterocytes and hepatocytes: a comparative analysis in paired tissue specimens [abstract]. Clin Pharmacol Ther 2004;75:172-83
   PubMed Web of Science ®Google Scholar
• Krishna D, Klotz U. Extrahepatic metabolism of drugs in humans. Clin Pharmacokinet 1994;26:144-60
   PubMed Web of Science ®Google Scholar
• Takemoto K, Yamazaki H, Tanaka Y, et al. Catalytic activities of cytochrome P450 enzymes and UDP-glucuronosyltransferases involved in drug metabolism in rat everted sacs and intestinal microsomes. Xenobiotica 2003;33:43-55
   PubMed Web of Science ®Google Scholar
• Thörn M, Finnström N, Lundgren S, et al. Cytochromes P450 and MDR1 mRNA expression along the human gastrointestinal tract. Br J Clin Pharmacol 2005;60:54-60
   PubMed Web of Science ®Google Scholar
• Wacher VJ, Salphati L, Benet LZ. Active secretion and enterocytic drug metabolism barriers to drug absorption. Adv Drug Deliv Rev 2001;46:89-102
   PubMed Web of Science ®Google Scholar
• Kolars JC, Schmiedlin-Ren P, Schuetz JD, et al. Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytes. J Clin Invest 1992;90:1871-8
   PubMed Web of Science ®Google Scholar
• Deferme S, Annaert P, Augustijns P. In vitro screening models to assess intestinal drug absorption and metabolism. In: Ehrhardt C, Kim K-J, editors. Drug absorption studies. Springer; US: 2008. p. 182-215
   Google Scholar
• Murakami T, Takano M. Intestinal efflux transporters and drug absorption. Expert Opin Drug Metab Toxicol 2008;4:923-39
   PubMed Web of Science ®Google Scholar
• Yokooji T, Yumoto R, Nagai J, et al. Role of intestinal efflux transporters in the intestinal absorption of methotrexate in rats. J Pharm Pharmacol 2007;59:1263-70
   PubMed Web of Science ®Google Scholar
• Mouly S, Paine M. P-Glycoprotein increases from proximal to distal regions of human small intestine. Pharm Res 2003;20:1595-9
   PubMed Web of Science ®Google Scholar
• Meier Y, Eloranta JJ, Darimont J, et al. Regional distribution of solute carrier mRNA expression along the human intestinal tract. Drug Metab Dispos 2007;35:590-4
   PubMed Web of Science ®Google Scholar
• Englund G, Rorsman F, Rönnblom A, et al. Regional levels of drug transporters along the human intestinal tract: co-expression of ABC and SLC transporters and comparison with Caco-2 cells. Eur J Pharm Sci 2006;29:269-77
   PubMed Web of Science ®Google Scholar
• Hu M, Ling J, Lin H, Chen J. Use of Caco-2 cell monolayers to study drug absorption and metabolism. In: Yan Z, Caldwell G, editors. Methods in pharmacology and toxicology optimization in drug discovery: in vitro methods. Humana Press; Totowa, New Jersey: 2004. p. 19-35
   Google Scholar
• Carrière V, Chambaz J, Rousset M. Intestinal responses to xenobiotics. Toxicol in Vitro 2001;15:373-8
   PubMed Web of Science ®Google Scholar
• Borlak J, Zwadlo C. Expression of drug-metabolizing enzymes, nuclear transcription factors and ABC transporters in Caco-2 cells. Xenobiotica 2003;33:927-43
   PubMed Web of Science ®Google Scholar
• Taipalensuu J, Törnblom H, Lindberg G, et al. Correlation of gene expression of ten drug efflux proteins of the ATP-binding cassette transporter family in normal human jejunum and in human intestinal epithelial Caco-2 cell monolayers. J Pharmacol Exp Ther 2001;299:164-70
   PubMed Web of Science ®Google Scholar
• Maubon N, Le Vee M, Fossati L, et al. Analysis of drug transporter expression in human intestinal Caco-2 cells by real-time PCR. Fundam Clin Pharmacol 2007;21:659-63
   PubMed Web of Science ®Google Scholar
• Sambuy Y, Angelis I, Ranaldi G, et al. The Caco-2 cell line as a model of the intestinal barrier: influence of cell and culture-related factors on Caco-2 cell functional characteristics. Cell Biol Toxicol 2005;21:1-26
   PubMed Web of Science ®Google Scholar
• Siissalo S, Heikkinen AT. In vitro methods to study the interplay of drug metabolism and efflux in the intestine. Curr Drug Metab 2013;14:102-11
   PubMed Web of Science ®Google Scholar
• van de Kerkhof EG, Ungell A-LB, Sjöberg ÅK, et al. Innovative methods to study human intestinal drug metabolism in vitro: precision-cut slices compared with ussing chamber preparations. Drug Metab Dispos 2006;34:1893-902
   PubMed Web of Science ®Google Scholar
• Groothuis G, de Graaf I. Precision-cut intestinal slices as in vitro tool for studies on drug metabolism. Curr Drug Metab 2013;14:112-19
   PubMed Web of Science ®Google Scholar
• Yu J, Peng S, Luo D, March JC. In vitro 3D human small intestinal villous model for drug permeability determination. Biotechnol Bioeng 2012;109:2173-8
   PubMed Web of Science ®Google Scholar
• Li N, Wang D, Sui Z, et al. Development of an improved three-dimensional in vitro intestinal mucosa model for drug absorption evaluation. Tissue Eng Part C Methods 2013;19:1-12
   PubMedGoogle Scholar
• Antunes F, Andrade F, Araujo F, et al. Establishment of a triple co-culture in vitro cell models to study intestinal absorption of peptide drugs. Eur J Pharm Biopharm 2013;83:427-35
   PubMed Web of Science ®Google Scholar
• Hukkanen J, Pelkonen O, Hakkola J, Raunio H. Expression and regulation of xenobiotic-metabolizing cytochrome P450 (CYP) enzymes in human lung. Crit Rev Toxicol 2002;32:391-411
   PubMed Web of Science ®Google Scholar
• Castell JV, Teresa Donato M, Gómez-Lechón MJ. Metabolism and bioactivation of toxicants in the lung. The in vitro cellular approach. Exp Toxicol Pathol 2005;57:189-204
   PubMed Web of Science ®Google Scholar
• Foster KA, Oster CG, Mayer MM, et al. Characterization of the A549 cell line as a type II pulmonary epithelial cell model for drug metabolism. Exp Cell Res 1998;243:359-66
   PubMed Web of Science ®Google Scholar
• Newland N, Baxter A, Hewitt K, Minet E. CYP1A1/1B1 and CYP2A6/2A13 activity is conserved in cultures of differentiated primary human tracheobronchial epithelial cells. Toxicol in Vitro 2011;25:922-9
   PubMed Web of Science ®Google Scholar
• Foster KA, Avery ML, Yazdanian M, Audus KL. Characterization of the Calu-3 cell line as a tool to screen pulmonary drug delivery. Int J Pharm 2000;208:1-11
   PubMed Web of Science ®Google Scholar
• Forbes B, Ehrhardt C. Human respiratory epithelial cell culture for drug delivery applications. Eur J Pharm Biopharm 2005;60:193-205
   PubMed Web of Science ®Google Scholar
• Florea BI, Cassara ML, Junginger HE, Borchard G. Drug transport and metabolism characteristics of the human airway epithelial cell line Calu-3. J Control Release 2003;87:131-8
   PubMed Web of Science ®Google Scholar
• Forbes B. Human airway epithelial cell lines for in vitro drug transport and metabolism studies. Pharm Sci Technol Today 2000;3:18-27
   PubMedGoogle Scholar
• Ehrhardt C, Kneuer C, Fiegel J, et al. Influence of apical fluid volume on the development of functional intercellular junctions in the human epithelial cell line 16HBE14o–: implications for the use of this cell line as an in vitro model for bronchial drug absorption studies. Cell Tissue Res 2002;308:391-400
   PubMed Web of Science ®Google Scholar
• Proud D, Subauste MC, Ward PE. Glucocorticoids do not alter peptidase expression on a human bronchial epithelial cell line. Am J Respir Cell Mol Biol 1994;11:57-65
   PubMed Web of Science ®Google Scholar
• Eaton E, Walle U, Wilson H, et al. Stereoselective sulphate conjugation of salbutamol by human lung and bronchial epithelial cells. Br J Clin Pharmacol 1996;41:201-6
   PubMed Web of Science ®Google Scholar
• Garcia-Canton C, Minet E, Anadon A, Meredith C. Metabolic characterization of cell systems used in in vitro toxicology testing: Lung cell system BEAS-2B as a working example. Toxicol In Vitro published online 10 May 2013; doi:10.1016/j.tiv.2013.05.001
   Web of Science ®Google Scholar
• Persoz C, Achard S, Momas I, Seta N. Inflammatory response modulation of airway epithelial cells exposed to formaldehyde. Toxicol Lett 2012;211:159-63
   PubMed Web of Science ®Google Scholar
• Veljkovic E, Jiricny J, Menigatti M, et al. Chronic exposure to cigarette smoke condensate in vitro induces epithelial to mesenchymal transition-like changes in human bronchial epithelial cells, BEAS-2B. Toxicol In Vitro 2011;25:446-53
   PubMed Web of Science ®Google Scholar
• Haniu H, Saito N, Matsuda Y, et al. Effect of dispersants of multi-walled carbon nanotubes on cellular uptake and biological responses. Int J Nanomed 2011;6:3295-307
   PubMed Web of Science ®Google Scholar
• Courcot E, Leclerc J, Lafitte J-J, et al. Xenobiotic metabolism and disposition in human lung cell models: comparison with in vivo expression profiles. Drug Metab Dispos 2012;40:1953-65
   PubMed Web of Science ®Google Scholar
• Lehmann AD, Daum N, Bur M, et al. An in vitro triple cell co-culture model with primary cells mimicking the human alveolar epithelial barrier. Eur J Pharm Biopharm 2011;77:398-406
   PubMed Web of Science ®Google Scholar
• Lohr JW, Willsky GR, Acara MA. Renal drug metabolism. Pharmacol Rev 1998;50:107-42
   PubMed Web of Science ®Google Scholar
• Murray GI, McFadyen MCE, Mitchell RT, et al. Cytochrome P450 CYP3A in human renal cell cancer. Br J Cancer 1999;79:1836-42
   PubMed Web of Science ®Google Scholar
• Haehner BD, Gorski JC, Vandenbranden M, et al. Bimodal distribution of renal cytochrome P450 3A activity in humans. Mol Pharmacol 1996;50:52-9
   PubMed Web of Science ®Google Scholar
• Loaiza-PÉRez AI, Kenney S, Boswell J, et al. Sensitivity of renal cell carcinoma to aminoflavone: role of CYP 1A1. J Urol 2004;171:1688-97
   PubMed Web of Science ®Google Scholar
• Vrignaud P, Sémiond D, Lejeune P, et al. Preclinical antitumor activity of cabazitaxel, a semisynthetic taxane active in taxane-resistant tumors. Clin Cancer Res 2013;19:2973-83
   PubMed Web of Science ®Google Scholar
• Glube N, Giessl A, Wolfrum U, Langguth P. Caki-1 cells represent an in vitro model system for studying the human proximal tubule epithelium. Nephron Exp Nephrol 2007;107:47-56
   Google Scholar
• Mullin JM, Cha CJ, Kleinzeller A. Metabolism of L-lactate by LLC-PK1 renal epithelia. Am J Physiol 1982;242:41-5
   Google Scholar
• Baudoin R, Griscom L, Monge M, et al. Development of a renal microchip for in vitro distal tubule models. Biotechnol Prog 2007;23:1245-53
   PubMed Web of Science ®Google Scholar
• Choucha-Snouber L, Griscom L, Poleni P, et al. Liver-kidney microfluid bioreactor for cell co-culture in drug studies. 14th International Conference on Miniaturized Systems for Chemistry and Life Sciences; 2010. p. 833-5
   Google Scholar
• Subramanian B, Rudym D, Cannizzaro C, et al. Tissue-engineered three-dimensional in vitro models for normal and diseased kidney. Tissue Eng Part A 2010;16:2821-31
   PubMed Web of Science ®Google Scholar
• Xu J, Patton D, Jackson SK, Purcell WM. In-vitro maintenance and functionality of primary renal tubules and their application in the study of relative renal toxicity of nephrotoxic drugs. J Pharmacol Toxicol Methods 2013;68:269-74
   PubMed Web of Science ®Google Scholar
• Enomoto A, Niwa T. Roles of organic anion transporters in the progression of chronic renal failure. Ther Apher Dial 2007;11:27-31
   PubMedGoogle Scholar